Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to ESCC
Related studies linked through entity extraction aliases.
Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )
- Status
- UNKNOWN
- Phase
- PHASE2
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer
- Status
- UNKNOWN
- Phase
- NA